Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CALL
Micron Technology
MU
$1.09T
| $73.4M | 0.04% |
1,163,500
+140,500
| +14% | +$9.03M |
|
502
Las Vegas Sands
LVS
$30.5B
| $73.1M | 0.04% |
1,261,059
+643,421
| +104% | +$38.1M |
|
503
PUT
PayPal
PYPL
$52.7B
| $73M | 0.04% |
1,094,600
+506,300
| +86% | +$34.5M |
|
504
PUT
Boston Scientific
BSX
$73B
| $73M | 0.04% |
1,349,100
+3,700
| +0.3% | +$193K |
|
505
PUT
Marriott International
MAR
$92.9B
| $72.7M | 0.04% |
396,000
+101,600
| +35% | +$17.6M |
|
506
CALL
Novartis
NVS
$302B
| $72.4M | 0.04% |
717,500
+202,000
| +39% | +$20.2M |
|
507
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| $72.4M | 0.04% |
561,900
+44,600
| +9% | +$5.59M |
|
508
CALL
United Parcel Service
UPS
$86.8B
| $72.3M | 0.04% |
403,500
+229,400
| +132% | +$40.7M |
|
509
AptarGroup
ATR
$8.57B
| $72.2M | 0.04% |
623,491
+612,603
| +5,626% | +$71.8M |
|
510
Broadridge
BR
$20.8B
| $72.1M | 0.04% |
435,425
+66,563
| +18% | +$10.1M |
|
|
VMRK
511
Vivmark Residential
VMRK
$25B
| $71.5M | 0.04% |
1,083,981
-172,601
| -14% | -$10.8M |
|
512
Brown & Brown
BRO
$24.4B
| $71.4M | 0.04% |
1,037,128
-518,643
| -33% | -$33M |
|
|
JHG
513
DELISTED
Janus Henderson
JHG
| $71.3M | 0.04% |
2,617,690
+2,557,781
| +4,269% | +$68.2M |
|
514
PUT
McDonald's
MCD
$192B
| $71.3M | 0.04% |
239,000
-58,400
| -20% | -$17M |
|
515
SM Energy
SM
$8.85B
| $71.3M | 0.04% |
2,253,592
-9,858
| -0.4% | -$278K |
|
516
Henry Schein
HSIC
$9.86B
| $71.1M | 0.04% |
876,497
+865,276
| +7,711% | +$68.4M |
|
517
PUT
Nike
NKE
$60.5B
| $71.1M | 0.04% |
643,800
+265,900
| +70% | +$31.1M |
|
518
PUT
AutoZone
AZO
$48.3B
| $70.8M | 0.03% |
28,400
-1,800
| -6% | -$4.59M |
|
519
CALL
Edwards Lifesciences
EW
$51.8B
| $70.5M | 0.03% |
747,600
+695,000
| +1,321% | +$60.4M |
|
520
Vistra
VST
$45.7B
| $70.4M | 0.03% |
2,680,562
-204,228
| -7% | -$4.99M |
|
521
M&T Bank
MTB
$34.7B
| $70.1M | 0.03% |
566,606
+86,860
| +18% | +$10.5M |
|
522
NextEra Energy
NEE
$174B
| $70.1M | 0.03% |
944,817
-75,655
| -7% | -$5.73M |
|
523
CALL
Caterpillar
CAT
$381B
| $70.1M | 0.03% |
284,800
+123,700
| +77% | +$27.6M |
|
|
524
Linde
LIN
$225B
| $70M | 0.03% |
183,770
-1,020,075
| -85% | -$373M |
|
525
Jazz Pharmaceuticals
JAZZ
$16.5B
| $70M | 0.03% |
564,287
-631,294
| -53% | -$84.9M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.